People: Procter & Gamble Co (PG.N)

PG.N on New York Stock Exchange

2 Jul 2020
Change (% chg)

$0.90 (+0.75%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Jimenez, Joseph 

Mr. Joseph S. Jimenez is an Independent Director of the Company. Mr. Jimenez is Co-Founder and Managing Partner of Aditum Bio (a biotech venture fund that launched in July 2019). He is the former Chief Executive Officer of Novartis AG (global healthcare company), a position he held from 2010 to 2018. Prior to this role, he held several other senior positions at Novartis from April 2007 to 2010, as well as various leadership roles at H. J. Heinz Company in Europe and North America from 1999 to 2006 and at ConAgra Foods from 1993 to 1998. He was also an Advisor to the Blackstone Group L.P. from 2006 to 2007. Mr. Jimenez has been a Director of General Motors since 2015. He was a Director of Colgate-Palmolive from 2010 to 2015. Mr. Jimenez’s demonstrated track record of International business Leadership, Strategy, and Risk Management and the Digital, Technology, and Innovation experience he gained through his role as CEO of Novartis and other roles at a range of Consumer Industry/Retail companies, such as H.J. Heinz and ConAgra, enables him to provide unique perspective to the Board on commercial, innovation, Marketing, and strategic issues. The Board also benefits from Mr. Jimenez’s extensive knowledge of the healthcare industry, particularly as the Company works to integrate Merck KGaA’s Consumer Health Business.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 175,000
Long-Term Incentive Plans, USD --
All Other, USD 110,000
Fiscal Year Total, USD 285,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Taylor


Jon Moeller


Laura Becker


Steven Bishop


Gary Coombe


Jennifer Davis

As Of  30 Jun 2019